JD Health International Inc.
JDHIY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $58,160 | $53,530 | $46,736 | $30,682 |
| % Growth | 8.6% | 14.5% | 52.3% | – |
| Cost of Goods Sold | $44,851 | $41,665 | $36,845 | $23,485 |
| Gross Profit | $13,309 | $11,865 | $9,892 | $7,197 |
| % Margin | 22.9% | 22.2% | 21.2% | 23.5% |
| R&D Expenses | $1,330 | $1,226 | $1,067 | $893 |
| G&A Expenses | $1,419 | $1,998 | $2,154 | $5,536 |
| SG&A Expenses | $4,468 | $4,653 | $4,349 | $7,670 |
| Sales & Mktg Exp. | $3,049 | $2,655 | $2,196 | $2,134 |
| Other Operating Expenses | $6,032 | $0 | $83 | $0 |
| Operating Expenses | $11,830 | $11,234 | $9,938 | $8,563 |
| Operating Income | $1,479 | $631 | $803 | -$857 |
| % Margin | 2.5% | 1.2% | 1.7% | -2.8% |
| Other Income/Exp. Net | $3,318 | $2,063 | $841 | -$44 |
| Pre-Tax Income | $4,797 | $2,693 | $696 | -$901 |
| Tax Expense | $640 | $550 | $313 | $171 |
| Net Income | $4,162 | $2,142 | $380 | -$1,074 |
| % Margin | 7.2% | 4% | 0.8% | -3.5% |
| EPS | 1.32 | 0.69 | 0.12 | -0.35 |
| % Growth | 91.3% | 475% | 134.3% | – |
| EPS Diluted | 1.32 | 0.68 | 0.12 | -0.35 |
| Weighted Avg Shares Out | 3,140 | 3,124 | 3,107 | 3,095 |
| Weighted Avg Shares Out Dil | 3,156 | 3,164 | 3,144 | 3,095 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,961 | $1,949 | $864 | $458 |
| Interest Expense | $8 | $9 | $9 | $6 |
| Depreciation & Amortization | $215 | $227 | $141 | $63 |
| EBITDA | $5,020 | $858 | $944 | -$832 |
| % Margin | 8.6% | 1.6% | 2% | -2.7% |